The dual marker test, also known as the double marker test, measures the levels of beta human chorionic gonadotropin (beta hcg) and pregnancy associated plasma protein (papp-a) in the blood to screen for genetic abnormalities in the fetus, such as Down's syndrome or trisomy 18. It is ideally conducted between 10-13 weeks of pregnancy, though can be performed between 9-13.6 weeks. This test is recommended for women with a family history of genetic disorders and those over 35 years old, often in conjunction with a nuchal translucency test for more accurate diagnosis.